Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | -7.43% | -14.56% | +33.66% |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.66% | 91.19M | |
+4.42% | 111B | |
+11.19% | 105B | |
-12.11% | 22.34B | |
-3.93% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-9.23% | 16.96B | |
+3.08% | 13.7B | |
+36.30% | 12.45B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Chardan Research Adjusts Passage Bio's Price Target to $34 From $43; Buy Rating Kept